van Houte Hans
Reporting owner on Forms 3, 4 and 5, CIK 1817217.
van Houte Hans reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NRIX · Nurix Therapeutics, Inc.CIK 1549595 | officer (Chief Financial Officer) | 2 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-11-04 | S sold | -3,300 | $15.3824 | 44,214 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-11-04 | S sold | -1,469 | $16.2018 | 42,745 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +3,750 | $0 | 43,916 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +2,859 | $0 | 46,775 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +3,573 | $0 | 50,348 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | S sold | -2,834 | $26.2791 | 47,514 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -3,750 | $0 | 7,500 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -2,859 | $0 | 17,150 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -3,573 | $0 | 35,730 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001817217-26-000016 | Nurix Therapeutics, Inc. | 2026-11-04 | ||
| Form 4 0001817217-26-000014 | Nurix Therapeutics, Inc. | 2026-11-02 |